Chemours Co Files 8-K with Financial Exhibits
Ticker: CC · Form: 8-K · Filed: Mar 26, 2024 · CIK: 1627223
| Field | Detail |
|---|---|
| Company | Chemours Co (CC) |
| Form Type | 8-K |
| Filed Date | Mar 26, 2024 |
| Risk Level | low |
| Pages | 2 |
| Reading Time | 2 min |
| Key Dollar Amounts | $0.01 |
| Sentiment | neutral |
Sentiment: neutral
Topics: financial-reporting, exhibits
TL;DR
Chemours filed an 8-K with financial exhibits on 3/26/24.
AI Summary
On March 26, 2024, The Chemours Company filed an 8-K report. The filing primarily concerns financial statements and exhibits, indicating updates or disclosures related to the company's financial performance and operations. No specific material events or transactions are detailed in the provided excerpt.
Why It Matters
This filing provides updated financial information and exhibits for The Chemours Company, which is crucial for investors and stakeholders to assess the company's financial health and operational status.
Risk Assessment
Risk Level: low — The filing is a routine 8-K report primarily containing financial statements and exhibits, with no immediate indication of significant new risks or material adverse events.
Key Numbers
- 001-36794 — Commission File Number (Identifies the company's SEC filing record.)
- 46-4845564 — I.R.S. Employer Identification No. (Company's tax identification number.)
Key Players & Entities
- The Chemours Company (company) — Registrant
- Delaware (location) — State of Incorporation
FAQ
What specific financial statements or exhibits are included in this 8-K filing?
The provided excerpt states the filing includes 'Financial Statements and Exhibits' but does not specify the exact nature or content of these documents.
Does this 8-K report announce any new material events or transactions for The Chemours Company?
The excerpt indicates the filing is for 'Regulation FD Disclosure' and 'Financial Statements and Exhibits,' but does not detail any specific new material events or transactions.
What is the date of the earliest event reported in this filing?
The date of the earliest event reported is March 26, 2024.
Where is The Chemours Company's principal executive office located?
The principal executive offices are located at 1007 Market Street, Wilmington, Delaware 19801.
What is the company's standard industrial classification code?
The company's Standard Industrial Classification code is 2800, which falls under CHEMICALS & ALLIED PRODUCTS.
Filing Stats: 549 words · 2 min read · ~2 pages · Grade level 10.6 · Accepted 2024-03-26 17:30:32
Key Financial Figures
- $0.01 — ange on Which Registered Common Stock ($0.01 par value) CC New York Stock Exchan
Filing Documents
- d782971d8k.htm (8-K) — 24KB
- d782971dex991.htm (EX-99.1) — 7KB
- g782971dsp1.jpg (GRAPHIC) — 7KB
- g782971dsp_1snap1.jpg (GRAPHIC) — 3KB
- 0001193125-24-077725.txt ( ) — 163KB
- cc-20240326.xsd (EX-101.SCH) — 3KB
- cc-20240326_lab.xml (EX-101.LAB) — 17KB
- cc-20240326_pre.xml (EX-101.PRE) — 11KB
- d782971d8k_htm.xml (XML) — 3KB
Financial Statements and Exhibits
Financial Statements and Exhibits. (d) Exhibits Exhibit No. Description 99.1 Press Release, dated March 26, 2024 104 Cover Page Interactive Data File (embedded within the Inline XBRL document).
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. THE CHEMOURS COMPANY Date: March 26, 2024 By: /s/ Matthew S. Abbott Name: Matthew S. Abbott Title: Interim Chief Financial Officer